These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31718543)

  • 1. Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study.
    Keller MS; Jusufagic A; Spiegel BMR
    BMC Gastroenterol; 2019 Nov; 19(1):182. PubMed ID: 31718543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
    LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Patient-Provider Interactions Regarding the Burden and Treatment of Opioid-Induced Constipation in Adults with Chronic Noncancer Pain.
    Vallerand AH; Hendry S; Baldys E; Hu Y; Datto C
    Pain Med; 2019 May; 20(5):889-896. PubMed ID: 30125008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey.
    Gupta S; Patel H; Scopel J; Mody RR
    J Opioid Manag; 2015; 11(4):325-38. PubMed ID: 26312960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-Induced Constipation Survey in Patients with Chronic Noncancer Pain.
    Rauck RL; Hong KJ; North J
    Pain Pract; 2017 Mar; 17(3):329-335. PubMed ID: 26990277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sources and Impact of Time Pressure on Opioid Management in the Safety-Net.
    Satterwhite S; Knight KR; Miaskowski C; Chang JS; Ceasar R; Zamora K; Kushel M
    J Am Board Fam Med; 2019; 32(3):375-382. PubMed ID: 31068401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of opioid-induced constipation.
    Prichard D; Norton C; Bharucha AE
    Br J Nurs; 2016 May 26-Jun 8; 25(10):S4-5, S8-11. PubMed ID: 27231750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care.
    Cooke AC; Knight KR; Miaskowski C
    Int J Drug Policy; 2019 Jan; 63():23-28. PubMed ID: 30472467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Overview and Considerations for the Management of Opioid-induced Constipation in Patients With Chronic Noncancer Pain.
    Viscusi ER
    Clin J Pain; 2019 Feb; 35(2):174-188. PubMed ID: 30289777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When People with Opioid-Induced Constipation Speak: A Patient Survey.
    Epstein RS; Teagarden JR; Cimen A; Sostek M; Salimi T
    Adv Ther; 2017 Mar; 34(3):725-731. PubMed ID: 28181146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey.
    Bell T; Annunziata K; Leslie JB
    J Opioid Manag; 2009; 5(3):137-44. PubMed ID: 19662923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-induced constipation, use of laxatives, and health-related quality of life.
    Christensen HN; Olsson U; From J; Breivik H
    Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer.
    Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A
    J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
    Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
    Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ
    Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada.
    Goeree R; Goeree J
    J Med Econ; 2016; 19(3):277-91. PubMed ID: 26535790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evolving Role of Long-Term Pharmacotherapy for Opioid-Induced Constipation in Patients Being Treated for Noncancer Pain.
    Bowers BL; Crannage AJ
    J Pharm Pract; 2019 Oct; 32(5):558-567. PubMed ID: 29207909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use.
    Knight KR; Kushel M; Chang JS; Zamora K; Ceasar R; Hurstak E; Miaskowski C
    Soc Sci Med; 2017 Aug; 186():87-95. PubMed ID: 28599142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-Induced Constipation in Oncological Patients: New Strategies of Management.
    Mesía R; Virizuela Echaburu JA; Gómez J; Sauri T; Serrano G; Pujol E
    Curr Treat Options Oncol; 2019 Dec; 20(12):91. PubMed ID: 31853656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
    Webster LR; Brewer RP; Lichtlen P; Losch-Beridon T; Mareya S; Wang M
    Pain Med; 2018 Jun; 19(6):1195-1205. PubMed ID: 29897589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.